View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist
ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist
ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist
ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist

A reassuring quarter

Broad-based strength behind 10% adj. EBITA beat, '24e-'26e adj. EBITA up 4-2%; 4% CAGR '23-'26e, keep HOLD, TP SEK 340 (310)

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist
ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist

Serial acquirers: M&A in the driver's seat

M&A upside, organic rebound H2'24 and margin resilience. '24e-'26e EBITA/EPS roughly unchanged, '24 likely a slower year. Reinvestment & ROIC motivate 23x EBITA, ADDT/LAGR up to BUY.

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist

Earnings likely negative in Q2

Calendar Q2 due Friday, 12 July. '24e-'26e EBITA up 1%; 4% CAGR '23-'26e, keep HOLD, TP SEK 310 (250)

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist

Serial acquirers Q1 recap: organic slowdown continues

Q1 recap: lower volumes, but strong margins, 1-3% adj. EBITA miss, '24e-'26e EBITA down 1-0% post-Q1, sector up 13% YTD (EPS up 5%), now trading at ~22x F12m EV/EBITA, 25% above 10Y avg.

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist

The worst is likely behind us

Up to HOLD (Sell), TP SEK 250 (245), '24e-'26e EBITA down 2-1%; 3% CAGR '23-'26e, Demolition weakness likely to persist until H2'24.

ABGSC Capital Goods Research ... (+2)
  • ABGSC Capital Goods Research
  • Karl Bokvist
Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Lifco - Another treat, but with a toothache

7% EBITA beat as cyclical businesses continue to shine ‘22e-‘24e EBITA up 2%; -9% y-o-y ‘23e, +8% ‘24e Keep BUY, TP SEK 170 (170)

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Lifco - 7% EBITA beat, but miss in Dental

Sales +2%, EBITA +7% vs. cons, miss in Dental Consensus to raise ‘22e EBITA 1-3%, ‘23e 0-2% Another solid report, but we fear it will not be enough

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Lifco - Heads-up for report 21 October

Lifco will report Q3 on Friday, 21 October, at 07:30 CET. A conference call will follow at 09:00, dial in: SE , UK 31

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Sector Report - Stronger for longer

Down to HOLD (Buy), TP SEK 150 (165) Calendar Q3 (fiscal Q2) report on Thursday, 27 October

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Lifco - The quality pick

Up to BUY (Hold), TP SEK 170 (185), 15% upside ‘22e EBITA up 1%, ‘23e-‘24e EBITA down 7-4% Q3 report on Friday, 21 October, at 07:30 CET

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Lifco - Reassuring earnings beat bodes well for Q3

Strong sales and better margins behind 12% EBITA beat Adj. EBITA up 5-3% ’22e-’24e (FX +1%) Keep HOLD, TP SEK 185 (180)

Karl Bokvist ... (+2)
  • Karl Bokvist
  • Max Bacco

Lifco - Cyclical businesses continue to outperform

Sales +6%, adj. EBITA +13% vs. cons, good org growth Consensus likely to raise EBITA by 4-5% for 2022e Strong report, mid single-digit positive reaction warranted

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch